...
首页> 外文期刊>Cell research. >Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA
【24h】

Regulation of alternative splicing of Bcl-x by IL-6, GM-CSF and TPA

机译:IL-6,GM-CSF和TPA对Bcl-x选择性剪接的调控

获取原文
获取原文并翻译 | 示例

摘要

The splicing of many alternative exons in the precursor messenger RNA (pre-mRNA) is regulated by extracellular factors but the underlying molecular bases remain unclear. Here we report the differential regulation of Bcl-x pre-mRNA splicing by extracellular factors and their distinct requirements for pre-mRNA elements. In K562 leukemia cells, treatment with rnterleukin-6 (IL-6) or granulocyte-macrophage colony stimulating factor (GM-CSF) reduced the proportion of the Bcl-xL variant mRNA while treatment with 12-O-tetradecanoylphorbol 13-acetate (IPA) had no effect. In U251 glioma cells, however, TPA efficiently increased the Bcl-xL level. These regulations were also seen for a transfected splicing reporter mini-gene Further analyses of deletion mutants indicate that nucleotides 1-176 of the downstream intron are required for the IL-6 effect, whereas additional nuc.leotides 177-284 are essential for the GM-CSF effect. As for the TPA effect, only nucleotides 1-76 are required in the downstream intron.Thus, IL-6, GM-CSF and TPA differentially regulate Bcl-x splicing and require specific intronic pre-mRNA sequences for their respective effects.
机译:前体信使RNA(pre-mRNA)中许多其他外显子的剪接受细胞外因子调控,但潜在的分子基础仍不清楚。在这里,我们报告细胞外因素对Bcl-x pre-mRNA剪接的差异调节及其对pre-mRNA元素的独特要求。在K562白血病细胞中,用白细胞介素6(IL-6)或粒细胞巨噬细胞集落刺激因子(GM-CSF)处理可降低Bcl-xL变体mRNA的比例,而用12-O-十四烷酰佛波醇13-乙酸盐(IPA)处理)无效。然而,在U251胶质瘤细胞中,TPA有效地增加了Bcl-xL水平。对于转染的剪接报告基因微型基因也观察到了这些规定。对缺失突变体的进一步分析表明,下游内含子的核苷酸1-176是IL-6效应所必需的,而其他核苷酸177-284对于GM是必不可少的。 -CSF效果。至于TPA的作用,下游内含子只需要1-76位核苷酸,因此,IL-6,GM-CSF和TPA差异调节Bcl-x剪接,并需要特定的内含子pre-mRNA序列才能发挥各自的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号